FDA Approves CLOZAPINE — Aurobindo Pharma Limited

Aurobindo Pharma Limited announced approval of its Abbreviated New Drug Application for the generic version of Clozapine (ANDA #206433), introducing a new oral alternative to the market just after the 2016 holiday season. The late-2016 launch will provide an additional commercial option to patients likely anticipating higher demand during post-holiday replenishments, creating fresh pricing pressure for established competitors in the neurological therapeutics space.